My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.

    Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH; FinnDiane Study Group.

    Diabetes. 2008 Sep;57(9):2480-7. Epub 2008 Jun 10.PMID: 18544706 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.

    Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K.

    Diabetes Care. 1997 May;20(5):745-52.PMID: 9135936 [PubMed - indexed for MEDLINE]Related articles

    3.

    Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.

    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr.

    Can J Cardiol. 1997 Mar;13(3):253-60.PMID: 9117913 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

    Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

    Diabet Med. 2004 Jan;21(1):52-8.PMID: 14706054 [PubMed - indexed for MEDLINE]Related articles

    5.

    Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.

    Thorn LM, Forsblom C, Wadén J, Saraheimo M, Tolonen N, Hietala K, Groop PH; Finnish Diabetic Nephropathy (FinnDiane) Study Group.

    Diabetes Care. 2009 May;32(5):950-2. Epub 2009 Feb 5.PMID: 19196885 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation]

    Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian. PMID: 18773746 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.

    Boney CM, Verma A, Tucker R, Vohr BR.

    Pediatrics. 2005 Mar;115(3):e290-6.PMID: 15741354 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

    Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Taskinen MR, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2005 Aug;28(8):2019-24.PMID: 16043748 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Orchard TJ, Forrest KY, Kuller LH, Becker DJ; Pittsburgh Epidemiology of Diabetes Complications Study.

    Diabetes Care. 2001 Jun;24(6):1053-9.PMID: 11375370 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.

    Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K.

    Diabetes Res Clin Pract. 2003 Jul;61(1):69-76.PMID: 12849925 [PubMed - indexed for MEDLINE]Related articles

    11.

    Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4.

    Forsblom CM, Sane T, Groop PH, Tötterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepäntalo M, Laatikainen L, Matikainen E, Teppo AM, Koskimies S, Groop L.

    Diabetologia. 1998 Nov;41(11):1253-62.PMID: 9833930 [PubMed - indexed for MEDLINE]Related articles

    12.

    The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

    Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT.

    JAMA. 2002 Dec 4;288(21):2709-16.PMID: 12460094 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity]

    Reindel J, Zander E, Heinke P, Kohnert KD, Allwardt C, Kerner W.

    Herz. 2004 Aug;29(5):463-9. German. PMID: 15340731 [PubMed - indexed for MEDLINE]Related articles

    14.

    Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan.

    Sasaki A, Horiuchi N, Hasegawa K, Uehara M.

    Diabetes Res Clin Pract. 1995 Jan;27(1):77-83.PMID: 7781497 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    17.

    Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2007 Feb;30(2):292-9.PMID: 17259497 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

    Kilpatrick ES, Rigby AS, Atkin SL.

    Diabetes Care. 2007 Mar;30(3):707-12.PMID: 17327345 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study).

    Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Kaski K, Ala-Korpela M, Groop PH.

    Cardiovasc Diabetol. 2009 Oct 6;8:54.PMID: 19804653 [PubMed - in process]Related articlesFree article

    20.

    Cardiovascular morbidity and mortality associated with the metabolic syndrome.

    Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L.

    Diabetes Care. 2001 Apr;24(4):683-9.PMID: 11315831 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity